Article | November 1, 2023

A Step-By-Step Approach To Digitalizing Biopharma Manufacturing: Part I

By Shawn Opatka, Vice President & GM Life Sciences at Honeywell

GettyImages-1272298861 digital transformation

Digital transformation offers tangible advantages in terms of time, cost, and efficiency. However, adopting new technology and altering established processes and procedures may introduce potential disruptions to operations.

This perceived risk is particularly significant in the context of biopharmaceutical manufacturing operations, where the expectation is to consistently produce flawless product batches. Such organizations cannot afford errors as their teams adapt to a digital learning curve. The mere anticipation of potential risks can lead some organizations to postpone digital upgrades, depriving manufacturers of the operational benefits that digitalization can provide.

There is no reason to delay this transition. Learn about a popular way to digitalize high-risk environments that can be achieved easily in biopharma manufacturing.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online

Honeywell Process Solutions